A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 240 participants.

Also called NCT07695597

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 240 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07695597
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07695597. Randomized; quadruple masking; primary purpose treatment. Start 2026-07-15 (actual); primary completion 2027-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia
Condition
Mixed Hyperlipidemia
Intervention (Drug)
SYH2070
Intervention (Drug)
Placebo
Lead sponsor
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct07695597
Content hash
b70ed9bd9a087747afb9112a933e67b4a965c45ec0172b28aec05a46b452fd07